Furthermore, individuals aged 1849, 5069, and 70 showed increased risks of 101%, 78%, and 71%, respectively, for any psychiatric disease when using GLP-1 RAs compared to non-users
Lancet 405 , 627636 (2025)
While compounded semaglutide is used by some for weight loss or managing diabetes, it is not FDA-approved for these purposes and may present risks due to the lack of regulation
As illustrated in Figure 1, activation of the cAMP/PKA/CREB axis promotes the differentiation of white adipocytes into thermogenic-like adipocytes and enhances brown adipose tissue activity, contributing to lipid metabolism regulation and energy balance 8
Metabolism : Promotes efficient calorie burning and aids in weight management